TrialClinical cancer research : an official journal of the American Association for Cancer Research2019

Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma.

Shailender Bhatia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.